Beyond COVID: Leveraging synthetic biology to advance the potential of mRNA-based vaccines

Join us for our recorded webinar presented at SynBioBeta 2023 to explore the groundbreaking potential of synthetic biology in advancing mRNA-based vaccines.

• Discover how Telesis Bio addresses the bottlenecks in vaccine discovery.
• Learn about the collaboration with RNAimmune and the BioXp platform for faster vaccine screening.
• Gain insights into the future of mRNA-based vaccines, including the potential of RNA encapsulation on the BioXp platform.

Presenters:

Eric Esser

President, Chief Operating Officer
Telesis Bio

David Brown, PhD.

Associate Director,
RNAimmune